Trial Profile
A Safety and Efficacy Evaluation of Sodium Nitrite Injection for the Prevention of Ischemia-Reperfusion Injury Associated With Acute Myocardial Infarction.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Sodium nitrite (Primary)
- Indications Myocardial infarction; Myocardial reperfusion injury
- Focus Adverse reactions; Therapeutic Use
- 25 Aug 2017 Status changed from recruiting to completed.
- 25 Mar 2013 Planned end date changed from 1 Sep 2012 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 15 Jul 2011 Planned end date changed from 1 Sep 2011 to 1 Sep 2012 as reported by ClinicalTrials.gov.